One mosquito protein weakens several deadly flaviviruses

The protein’s discovery could lead to treatments for Zika, dengue fever, and maybe even COVID-19.

Mosquitos aren’t just irritating — they’re also incredibly dangerous, spreading life-threatening diseases to hundreds of millions of people every year.

But now, researchers at the National Institutes of Health (NIH) have discovered a protein in mosquitoes that could help doctors treat patients with some of those same diseases — and maybe even COVID-19, too.

Fat-Covered Flaviviruses

The most well-known mosquito-borne disease — malaria — is caused by a parasite. However, several others, including Zika, West Nile, dengue, and yellow fever, are caused by flaviviruses.

One thing all flaviviruses have in common is that they have a protective coating (a “viral envelope”) made from fatty compounds called lipids.

When mosquitos dine on blood, their bodies increase production of a protein called AEG12, which helps them digest red blood cells.

But mosquitoes also make AEG12 when they get infected by flaviviruses. When AEG12 hits a virus, the protein swaps out some of its own lipids for those in the viral envelope, destabilizing the virus’s structure.

“It is as if AEG12 is hungry for the lipids that are in the virus membrane, so it gets rid of some of the lipids it has and exchanges them for the ones it really prefers,” researcher Geoffrey Mueller said in a press release.

“The protein has high affinity for viral lipids and steals them from the virus.”

AEG12 exchanges its lipids for those in the viral envelope of a flavivirus. Geoffrey Mueller

Targeting the Viral Envelope

Because AEG12 strongly inhibits flaviviruses, the researchers suspect it might be useful as part of a treatment in humans, too.

But flaviviruses aren’t the only type of virus with viral envelopes — coronaviruses also have them, and in the lab, AEG12 was able to weakly inhibit those as well.

It is as if AEG12 is hungry for the lipids that are in the virus membrane.

Geoffrey Mueller

Before the protein could be used against any diseases, though, researchers will need to overcome a big problem caused by its other purpose in mosquitos: blood digestion.

AEG12 helps mosquitoes digest blood by breaking open red blood cells. That’s something we want to avoid in people, so researchers would need to find a way to tweak the protein so it only interferes with viruses and leaves blood cells alone.

If they can do that, mosquitos might shift from being strictly the cause of many life-threatening diseases to being part of the solution for them, too.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Viruses may one day treat inflammatory bowel disease
Researchers have created a cocktail of viruses that may be able to treat inflammatory bowel diseases like Crohn’s.
Nanoparticle sensor can distinguish between viral and bacterial pneumonia
MIT researchers have designed a sensor that can distinguish between viral and bacterial pneumonia infections.
Yale study finds low levels of a hormone may predict long COVID
Yale and Icahn School of Medicine researchers may have found biomarkers for identifying long COVID.
novavax covid-19 vaccine
FDA authorizes new COVID-19 vaccine — and it’s not like the others
The FDA has issued an emergency use authorization for biotech company Novavax’s protein-based COVID-19 vaccine.
An old HIV drug may treat Down syndrome 
A common HIV drug could potentially be a Down syndrome treatment, improving cognition in mouse models of the condition.
Up Next
Ebola prevention
Subscribe to Freethink for more great stories